Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2001
10/11/2001CA2403735A1 Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2402586A1 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001CA2402078A1 Divided dose therapies with vascular damaging activity
10/11/2001CA2401948A1 Cd20/ige-receptor like molecules and uses thereof
10/11/2001CA2401888A1 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
10/11/2001CA2400858A1 Fused heterocyclic derivatives, their production and use
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001EP1142870A1 Novel ligands of nuclear receptor
10/10/2001EP1142579A2 Bone resorption inhibitors
10/10/2001EP1141339A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
10/10/2001EP1141332A1 Human cyclic nucleotide pdes
10/10/2001EP1141325A1 Ikk3 kinase
10/10/2001EP1141308A2 Group b streptococcus proteins, and their use
10/10/2001EP1141288A2 Lymphocytic membrane proteins
10/10/2001EP1141287A1 Pancreatic polypeptide zsig66
10/10/2001EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof
10/10/2001EP1141253A1 Crystalline form of activated trap and use thereof for structure-based drug design
10/10/2001EP1141241A2 Astrocytes, their preparation and uses thereof
10/10/2001EP1141235A2 (bifidobacterium) in the treatment of inflammatory disease
10/10/2001EP1141015A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001EP1140984A1 Selective inhibitors of mmp-12
10/10/2001EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140943A2 Substituted pyrroloindoles
10/10/2001EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods
10/10/2001EP1140938A2 High affinity inhibitors for target validation and uses thereof
10/10/2001EP1140927A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140916A1 Heteroaryl-cyclic acetals
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140897A1 Protease inhibitors
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140818A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140240A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells
10/10/2001EP1140212A2 The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
10/10/2001EP1140175A2 Antibodies to truncated vegf-d and uses thereof
10/10/2001EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof
10/10/2001EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation
10/10/2001EP1140149A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
10/10/2001EP1140138A2 Therapeutic applications of flint polypeptides
10/10/2001EP1140136A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
10/10/2001EP1140133A1 Controlled release formulation comprising gnrh-ii
10/10/2001EP1140125A1 Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
10/10/2001EP1140124A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine
10/10/2001EP1140120A2 Human brainiac-5
10/10/2001EP1140118A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
10/10/2001EP1140112A1 Use of etherlysophospholipids as antiinflammatory agents
10/10/2001EP1140098A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
10/10/2001EP1140089A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine
10/10/2001EP1140083A1 Novel compounds
10/10/2001EP1140078A2 Benzimidazole vascular damaging agents
10/10/2001EP1140076A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
10/10/2001EP1140072A1 Compounds and methods
10/10/2001EP1140069A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
10/10/2001EP1140038A1 Transdermal drug delivery system
10/10/2001EP1140021A1 Improved formulation for topical non-invasive application in vivo
10/10/2001EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
10/10/2001EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
10/10/2001CN1317043A Polypeptides and polynucleotides from coagulase-negative staphylocoui
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316903A Compositions and methods for treating and preventing bone diseases using tocotrienols
10/10/2001CN1316267A Medicine for treating hyperosteogeny
10/10/2001CN1316264A Hongsheng plaster for treating fracture and its preparing process
10/10/2001CN1316258A Natural drug fumigating liquid and its preparing process
10/10/2001CN1072668C Dihydrobenzofuran and related compounds useful and anti-inflammatory agents
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/10/2001CN1072500C Medicine for treatment of arthritis and its preparing process
10/10/2001CN1072495C Health-care mattress with functions dispelling wind and clearing away cold, removing dampness and warming kidney
10/10/2001CN1072494C Medicinal liquor for treatment of osteoproliferation, muscular dystrophy and rheumatism
10/09/2001US6300347 For therapy of tumor necrosis factor and interleukin-1 mediated diseases such as rheumatoid arthritis and diseases of bone metabolism, e.g. osteoporosis
10/09/2001US6300334 Thieno[2,3-d]pyrimidine-2,4-diones
10/09/2001US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents
10/09/2001US6300309 Treatment of osteoporosis in mamals with reduced cortical bone mineral density
10/09/2001US6300127 Bone mineralization proteins, DNA, vectors, expression systems
10/07/2001CA2304869A1 Method of medical treatment using uric acid or precursors thereof
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072826A2 Oncogenic osteomalacia-related gene 1
10/04/2001WO2001072823A1 Crystal structure of the (aml1 runt domain) / (cbfbeta) heterodimer and the ternary complex with dna
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
1 ... 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 ... 820